Related Experiment Video

Updated: Dec 10, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.7K

Discussing deactivation of implantable cardiac defibrillators

Rahul Bahl1, Simon Dubrey1

  • 1Department of Cardiology, Hillingdon Hospital, Uxbridge, UK.

British Journal of Hospital Medicine (London, England : 2005)
|August 27, 2020
PubMed

Insights

Deactivating implantable cardioverter defibrillators (ICDs) is crucial for patients with life-limiting conditions. This article explores the background and practical considerations for ICD deactivation decisions.

Area of Science:

  • Cardiology
  • Medical Ethics
  • Geriatrics

Background:

  • Implantable cardiac defibrillators (ICDs) are vital for preventing sudden cardiac death in patients with life-threatening arrhythmias.
  • Patients with ICDs often develop life-limiting conditions due to aging, frailty, and progressive cardiac or non-cardiac morbidity.
  • This progression presents a significant challenge regarding decisions to deactivate ICDs.

Purpose of the Study:

  • To discuss the background and rationale for deactivating implantable cardioverter defibrillators.
  • To outline practical considerations and decision-making frameworks for ICD deactivation in patients with life-limiting illnesses.

Main Methods:

  • Literature review on ICD deactivation.
  • Discussion of clinical scenarios and ethical considerations.
  • Analysis of practical approaches to device deactivation.

Main Results:

  • Deactivation decisions require careful consideration of the patient's prognosis and quality of life.
  • Ethical frameworks support deactivation when the burdens of the ICD outweigh its benefits.
  • Practical guidelines are needed to assist clinicians in these complex decisions.

Conclusions:

  • Deactivating implantable cardioverter defibrillators is an important aspect of end-of-life care for patients with life-limiting conditions.
  • A structured approach, considering both clinical and ethical factors, is essential for appropriate ICD deactivation.
  • Further guidance and discussion are needed to support healthcare professionals and patients in making these difficult decisions.

Keywords:
ArrhythmiaEthicsImplantable cardiac defibrillatorsPacemakerSudden death

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.7K

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
338
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
182
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
268
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.5K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
4.9K